76-90 of 883
CETP Inhibition and Obicetrapib: A New Era in Lipid Management
CardiologyCETP Inhibition and Obicetrapib: A New Era in Lipid Management
CETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
CardiologyCETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
Managing Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
GI InsightsManaging Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
CardiologyRedefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart MattersTimely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart MattersEquitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
- advertisement
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart MattersTranslating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Heart MattersStaging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart MattersAnalyzing Outpatient Worsening Heart Failure in ATTR-CM
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart MattersCurrent and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Heart MattersShared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
The Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
DermConsultThe Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
- advertisement
Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
Project Oncology®Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
Partnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
Perspectives with the AMAPartnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
On the Frontlines of COPDECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
